Viewing Study NCT00532857


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-07-19 @ 4:05 AM
Study NCT ID: NCT00532857
Status: COMPLETED
Last Update Posted: 2012-01-04
First Post: 2007-09-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
Sponsor: Jungsil Ro
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Patients with HER2 + stage II/III breast cancer View